DRI Healthcare Trust (TSE:DHT.UN) Shares Up 38.3%

DRI Healthcare Trust (TSE:DHT.UNGet Free Report)’s stock price shot up 38.3% during mid-day trading on Monday . The company traded as high as C$17.43 and last traded at C$17.33. 29,555 shares were traded during trading, a decline of 15% from the average session volume of 34,784 shares. The stock had previously closed at C$12.53.

Analysts Set New Price Targets

A number of analysts recently weighed in on DHT.UN shares. National Bankshares upped their target price on shares of DRI Healthcare Trust from C$22.00 to C$23.50 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Raymond James upgraded shares of DRI Healthcare Trust from an “outperform” rating to a “strong-buy” rating and increased their price target for the company from C$22.00 to C$24.00 in a research note on Friday, March 1st. CIBC increased their price target on shares of DRI Healthcare Trust from C$19.00 to C$19.50 and gave the company an “outperform” rating in a research note on Friday, March 1st. Stifel Nicolaus increased their price target on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Finally, Scotiabank increased their price target on shares of DRI Healthcare Trust from C$22.00 to C$24.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of C$21.83.

Read Our Latest Stock Analysis on DRI Healthcare Trust

DRI Healthcare Trust Stock Up 36.0 %

The business has a 50 day moving average price of C$15.61.

DRI Healthcare Trust Company Profile

(Get Free Report)

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Recommended Stories

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.